×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KNBWY – kirin hldgs co ltd s/adr (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KNBWY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/3
02:27 am
knbwy
Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration [Yahoo! Finance]
Low
Report
Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration [Yahoo! Finance]
2/1
07:03 pm
knbwy
Amgen Refocuses Pipeline As Rocatinlimab Exit Reshapes Dermatology Outlook [Yahoo! Finance]
Low
Report
Amgen Refocuses Pipeline As Rocatinlimab Exit Reshapes Dermatology Outlook [Yahoo! Finance]
1/31
08:44 am
knbwy
Kyowa Kirin to regain control of rocatinlimab development, commercialization [Yahoo! Finance]
Low
Report
Kyowa Kirin to regain control of rocatinlimab development, commercialization [Yahoo! Finance]
1/31
08:26 am
knbwy
Is Kyowa Kirin (TSE:4151) Pricing Look Attractive After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
Is Kyowa Kirin (TSE:4151) Pricing Look Attractive After Recent Share Price Weakness [Yahoo! Finance]
1/30
02:52 pm
knbwy
Amgen ends collaboration agreement with Kyowa Kirin for eczema asset [Seeking Alpha]
Low
Report
Amgen ends collaboration agreement with Kyowa Kirin for eczema asset [Seeking Alpha]
1/30
08:00 am
knbwy
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
Low
Report
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
1/29
11:12 pm
knbwy
???????????????????? : ??????????2035??121?1000?????????-????????????????CAGR9.2%?????? [CNET News]
Low
Report
???????????????????? : ??????????2035??121?1000?????????-????????????????CAGR9.2%?????? [CNET News]
1/24
07:11 pm
knbwy
Assessing Kirin Holdings Company (TSE:2503) Valuation After Recent Share Performance Mix [Yahoo! Finance]
Low
Report
Assessing Kirin Holdings Company (TSE:2503) Valuation After Recent Share Performance Mix [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/18
Health experts denounce Scheer’s comments on Canada’s Food Guide as ‘irresponsible’ and ‘disingenuous’ [Toronto Globe and Mail (Ontario, Canada)]
3.0%
8/6 Kirin to take 30.3% stake in Fancl for $1.2 billion [Reuters] 2.2%
8/7 Australian regulator flags concerns over Saputo's Tasmanian cheese business buyout [Reuters] 1.9%
10/12 Lipo Naturals New Supplement with Setria® Offers "Most Potent" Form of Oral Glutathione (GSH) 0.7%
4/26 Japan's Kirin cuts full-year profit outlook on Lion unit impairment [Reuters] 0.7%
3/18 Kyowa Kirin Asia Pacific Announces Establishment of Subsidiary in Australia 0.3%
10/15 Kyowa Hakko's Setria® is the No. 1 Selling Brand of Glutathione 0.2%
3/31 Plant-Based Butter Startup Fora Sees Partnership Opportunities In Dairy Sector [Forbes] 0.1%
10/10 Kirin Holdings Co Ltd (OTCMKTS: KNBWY) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. 0.0%
8/6 Kirin to take 30.3% stake in Fancl for $1.2 billion [Reuters] 2.2%
8/7 Australian regulator flags concerns over Saputo's Tasmanian cheese business buyout [Reuters] 1.9%
10/12 Lipo Naturals New Supplement with Setria® Offers "Most Potent" Form of Oral Glutathione (GSH) 0.7%
4/26 Japan's Kirin cuts full-year profit outlook on Lion unit impairment [Reuters] 0.7%
3/18 Kyowa Kirin Asia Pacific Announces Establishment of Subsidiary in Australia 0.3%
10/15 Kyowa Hakko's Setria® is the No. 1 Selling Brand of Glutathione 0.2%
3/31 Plant-Based Butter Startup Fora Sees Partnership Opportunities In Dairy Sector [Forbes] 0.1%
10/10 Kirin Holdings Co Ltd (OTCMKTS: KNBWY) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. 0.0%
TOP News Decliners
8/28
Kyowa Kirin Announces FDA Approval of NOURIANZ™ (istradefylline) for Use in Parkinson’s Disease
-2.5%
4/4 Kyowa Kirin Announces FDA Acceptance of Istradefylline (KW-6002) New Drug Application Resubmission in the US -2.2%
2/28 Dairy Farmers pull ad after complaints over alleged misleading the public [Business News Network (BNN) Energy & Resources (Canada)] -1.8%
3/6 Award Received from the Sexual Medicine Society of North America to Fund a Targazyme TZ101 Study to Reverse Erectile Dysfunction in Prostate Cancer Patients -0.8%
2/14 Ultragenyx and Kyowa's Crysvita shows long-term benefit in XLH study [Seeking Alpha] -0.5%
1/23 New Canada food guide has P.E.I. dairy farmers 'very concerned' [CBC (Canadian Broadcasting Corporation)] -0.2%
11/23 GSK and Kyowa Hakko Kirin inks deal in Japan for Daprodustat [Seeking Alpha] -0.1%
4/4 Kyowa Kirin Announces FDA Acceptance of Istradefylline (KW-6002) New Drug Application Resubmission in the US -2.2%
2/28 Dairy Farmers pull ad after complaints over alleged misleading the public [Business News Network (BNN) Energy & Resources (Canada)] -1.8%
3/6 Award Received from the Sexual Medicine Society of North America to Fund a Targazyme TZ101 Study to Reverse Erectile Dysfunction in Prostate Cancer Patients -0.8%
2/14 Ultragenyx and Kyowa's Crysvita shows long-term benefit in XLH study [Seeking Alpha] -0.5%
1/23 New Canada food guide has P.E.I. dairy farmers 'very concerned' [CBC (Canadian Broadcasting Corporation)] -0.2%
11/23 GSK and Kyowa Hakko Kirin inks deal in Japan for Daprodustat [Seeking Alpha] -0.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: